Home » Stocks » Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc. (AMPE)

Stock Price: $0.803 USD -0.057 (-6.62%)
Updated Aug 12, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 141.78M
Revenue (ttm) n/a
Net Income (ttm) -16.15M
Shares Out 176.54M
EPS (ttm) -0.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $0.803
Previous Close $0.860
Change ($) -0.057
Change (%) -6.62%
Day's Open 0.850
Day's Range 0.800 - 0.870
Day's Volume 2,307,780
52-Week Range 0.260 - 1.240

More Stats

Market Cap 141.78M
Enterprise Value 138.01M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 176.54M
Float 161.18M
EPS (basic) -0.1
EPS (diluted) -0.13
FCF / Share -0.11
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 13.10M
Short Ratio 2.93
Short % of Float 8.07%
Beta 2.07
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 24.01
Revenue n/a
Operating Income -20.94M
Net Income -16.15M
Free Cash Flow -18.64M
Net Cash 3.77M
Net Cash / Share 0.02
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -79.92%
ROE -185.05%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$4.00*
Low
4.00
Current: $0.803
High
4.00
Target: 4.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue------0.050.050.02-
Revenue Growth------0%166.67%--
Gross Profit------0.050.050.02-
Operating Income-18.58-11.18-15.68-17.08-24.17-31.45-24.02-11.82-11.13-6.70
Net Income-13.6333.99-51.89-19.16-24.11-31.31-24.01-11.59-18.36-8.05
Shares Outstanding13173.3665.3053.7751.9950.2338.2933.9826.0116.29
Earnings Per Share-0.14-0.12-0.79-0.36-0.62-0.76-0.63-0.34-0.71-0.49
Operating Cash Flow-15.38-12.14-11.41-14.62-26.44-30.74-19.13-9.72-9.13-2.63
Capital Expenditures-0.02-0.56-0.07-0.01-0.11-8.67-1.31--0.08-
Free Cash Flow-15.41-12.70-11.48-14.63-26.55-39.41-20.44-9.72-9.22-2.63
Cash & Equivalents6.537.598.245.0516.0350.3626.3517.7011.400.67
Total Debt1.210.48-------3.14
Net Cash / Debt5.327.118.245.0516.0350.3626.3517.7011.40-2.47
Assets14.0014.0315.3113.6050.4270.2736.0225.8519.480.74
Liabilities7.568.7949.496.9612.494.812.802.021.724.75
Book Value6.445.24-34.186.6337.0066.1233.0823.8317.76-4.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Ampio Pharmaceuticals, Inc.
Country United States
Employees 23
CEO Michael E. Macaluso

Stock Information

Ticker Symbol AMPE
Stock Exchange NYSE American
Sector Healthcare
Industry Biotechnology
Unique Identifier NYSEAMERICAN: AMPE

Description

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. It is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. The company's product pipeline includes Ampion, which is in phase III clinical trial, is an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.